ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
Gofore Oyj

Gofore Oyj (0CXS)

8.70
0.00
(0.00%)
마감 02 2월 1:30AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
8.70
매수가
0.00
매도가
0.00
거래량
0.00
0.00 일간 변동폭 0.00
8.70 52주 범위 8.70
market_cap
전일 종가
8.70
개장가
-
최근 거래 시간
(O)
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
39
발행 주식
15,660,000
배당수익률
-
주가수익률
7.60
주당순이익(EPS)
1.14
매출
190.5M
순이익
17.92M

Gofore Oyj 정보

섹터
Prepackaged Software
산업
Prepackaged Software
웹사이트
본부
Tampere, Fin
설립됨
-
Gofore Oyj is listed in the Prepackaged Software sector of the 런던증권거래소 with ticker 0CXS. The last closing price for Gofore Oyj was 8.70 €. Over the last year, Gofore Oyj shares have traded in a share price range of 8.70 € to 8.70 €.

Gofore Oyj currently has 15,660,000 shares in issue. The market capitalisation of Gofore Oyj is 136.24 € million. Gofore Oyj has a price to earnings ratio (PE ratio) of 7.60.

0CXS 최신 뉴스

Invitation to Gofore’s Capital Markets Day 2023

Invitation to Gofore’s Capital Markets Day 2023 Gofore PlcPress Release14 December 2022 Invitation to Gofore's Capital Markets Day on 13 January 2023 Gofore is pleased to invite investors...

Gofore updates its strategy and long-term financial targets – Changes in the management team

Gofore updates its strategy and long-term financial targets – Changes in the management team   Gofore Plc Other information disclosed according to the rules of the Exchange 14 December 2022...

Inside information: Gofore Plc’s Business Review 1-30 November 2022: Net sales 17.2 million euros, year on year growth over 50%

Inside information: Gofore Plc’s Business Review 1-30 November 2022: Net sales 17.2 million euros, year on year growth over 50% Gofore Plc 12 December 2022 at 1.25 p.m. EETInside Information...

Gofore Plc: Gofore’s financial calendar and Annual General Meeting in 2023

Gofore Plc: Gofore’s financial calendar and Annual General Meeting in 2023 Gofore PlcStock Exchange Release28 November 2022 at 3.46 p.m. Gofore’s financial calendar and Annual General Meeting...

Gofore Plc: Gofore Plc updates its disclosure policy

Gofore Plc: Gofore Plc updates its disclosure policy Gofore PlcStock Exchange Release28 November 2022 at 3.45 p.m. Gofore Plc updates its disclosure policy Gofore Plc’s Board of Directors has...

Inside information: Gofore Plc’s Business Review 1-31 October 2022: Net sales 14.6 million euros, eMundo acquisition expands international portfolio

Inside information: Gofore Plc’s Business Review 1-31 October 2022: Net sales 14.6 million euros, eMundo acquisition expands international portfolio Gofore Plc 8 November, 2022 at 2.40 p.m...

Inside information: Gofore continues growth by acquisitions – Acquires all shares of eMundo GmbH to strengthen presence on German market, pays part of purchase price by directed share issue, incentive plan for target company management

Inside information: Gofore continues growth by acquisitions – Acquires all shares of eMundo GmbH to strengthen presence on German market, pays part of purchase price by directed share issue...

Gofore Plc: Gofore Plc’s Business Review July-September 2022: Gofore’s growth 32%, record high net sales in September – Employee experience significantly improved

Gofore Plc: Gofore Plc’s Business Review July-September 2022: Gofore’s growth 32%, record high net sales in September – Employee experience significantly improved Gofore Plc18 October, 2022...

Gofore Plc: Gofore Plc’s new shares registered in the trade register

Gofore Plc: Gofore Plc’s new shares registered in the trade register Gofore Plc Stock Exchange Release 30 September, 2022 at 8 a.m. EET Gofore Plc’s new share registered in the trade...

Gofore Plc: Managers' transactions - Vilminko-Heikkinen

Gofore Plc: Managers' transactions - Vilminko-Heikkinen GOFORE PLC  MANAGERS’ TRANSACTIONS 20 SEPTEMBER 2022 AT 11.30 EET Gofore Plc - Managers' transactions...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1008.78.78.7208.7DE
4008.78.78.7218.7DE
12008.78.78.7398.7DE
26008.78.78.7318.7DE
52008.78.78.7288.7DE
156008.78.78.7298.7DE
260008.78.78.7208.7DE

0CXS - Frequently Asked Questions (FAQ)

What is the current Gofore Oyj share price?
The current share price of Gofore Oyj is 8.70 €
How many Gofore Oyj shares are in issue?
Gofore Oyj has 15,660,000 shares in issue
What is the market cap of Gofore Oyj?
The market capitalisation of Gofore Oyj is EUR 136.24M
What is the 1 year trading range for Gofore Oyj share price?
Gofore Oyj has traded in the range of 8.70 € to 8.70 € during the past year
What is the PE ratio of Gofore Oyj?
The price to earnings ratio of Gofore Oyj is 7.6
What is the cash to sales ratio of Gofore Oyj?
The cash to sales ratio of Gofore Oyj is 0.72
What is the reporting currency for Gofore Oyj?
Gofore Oyj reports financial results in EUR
What is the latest annual turnover for Gofore Oyj?
The latest annual turnover of Gofore Oyj is EUR 190.5M
What is the latest annual profit for Gofore Oyj?
The latest annual profit of Gofore Oyj is EUR 17.92M
What is the registered address of Gofore Oyj?
The registered address for Gofore Oyj is KALEVANTIE 2, TAMPERE, 33 100
What is the Gofore Oyj website address?
The website address for Gofore Oyj is www.gofore.com
Which industry sector does Gofore Oyj operate in?
Gofore Oyj operates in the PREPACKAGED SOFTWARE sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
AIQAiq Limited
4.00p
(33.33%)
37.88k
INSPInspirit Energy Holdings Plc
0.0036p
(28.57%)
1.43B
ALKAlkemy Capital Investments Plc
175.00p
(27.27%)
176.27k
KNBKanabo Group Plc
1.00p
(25.00%)
461.04k
TCFTheracryf Plc
1.125p
(25.00%)
6.72M
MET1Metals One Plc
0.275p
(-35.29%)
16.2M
PPSProton Motor Power Systems Plc
0.175p
(-22.22%)
848.7k
SYMESupply@me Capital Plc
0.0025p
(-19.35%)
372.49M
CGNRConroy Gold & Natural Resources Plc
2.15p
(-18.87%)
739.53k
ONCOncimmune Holdings Plc
10.40p
(-16.47%)
1.19M
INSPInspirit Energy Holdings Plc
0.0036p
(28.57%)
1.43B
NTVONativo Resources Plc
0.0018p
(-5.26%)
1.41B
MSMNMosman Oil And Gas Limited
0.041p
(10.81%)
1.22B
TRPTower Resources Plc
0.0295p
(0.00%)
691.76M
SYMESupply@me Capital Plc
0.0025p
(-19.35%)
372.49M
Kam8 Kam8 3 시간 전
LP just doesn't accept Settlement and go discovery🤞😆🤞, I don't think MMs want discovery so they might accept big money for settlement. 😆😆
NWBO
manibiotech manibiotech 3 시간 전
Agree
Usual few will pump this anyway 
NWBO
manibiotech manibiotech 3 시간 전
lol 
The ceiling has already been put at 40M shares
So dream on
NWBO
Deportes Deportes 3 시간 전
Gfy is that better?
ENZC
Hicham007 Hicham007 3 시간 전
Painful but nothing new...

I have averaged down my portfolio to 6.6$ down from 9.8 and I have now 140k shares and i am ready to increase it to 200k if the SP continues on  dropping.  By now Iova is my only stock market investment so we can say all In...

I am ready finan
IOVA
jammy32 jammy32 3 시간 전
As soon as Trump the genius mentioned Tariffs on pharmaceuticals, this puppy got sick and dropped seven cents. Not good. Shouldn’t Nasrat tell us what this means for Elite. Are we subject to the tariffs where is the API from. Is this a good thing or bad thing. Does nasrat know. Does he
API
rosemountbomber rosemountbomber 3 시간 전
Sleven am I understanding correctly that the Generics get their API from China and Amarin doesn't?
API
BlazingStocks BlazingStocks 3 시간 전
$ILLR Triller CEO Sean Kim joins Yahoo Finance to discuss the fight for TikTok's market share and the outlook for the creator economy:https://x.com/YahooFinance/status/1885453406485033258?t=ldZluPpc4DCzgBoH3GagOA&s=19
ILLR
barnstormer barnstormer 3 시간 전
OK Zadie, the judge only allowed a lousy 40 million shares. Still, consider the following (quick back of the envelope math)

40,000,000 shares / (2752(avg daily volume) x 252 (avg yearly trading days) = 700,104 avg yearly shares traded
40,000,000 shares / 700,104 = 57.14 years
NWBO
BlazingStocks BlazingStocks 3 시간 전
Thank you for sharing this! 
ILLR
VMLG17 VMLG17 3 시간 전
And they’d be stupid if they didn’t settle. If a jury learns that the MMs have continued spoofing after the lawsuit was filed, then damages could be more than any settlement amount, not to mention criminal charges later.
NWBO
Macod Macod 3 시간 전
CHANGE in outstanding shares. First change in over a year. Should be more shares reflected with next update. Those lucky enough to buy privates be on the lookout for your certs

O/S 526,142,269
Restricted 297,633,160
Unrestricted 228,509,109

Increase of 7,6
MRGE
mascale mascale 3 시간 전
Hiru Prepared: Likely for new JORC, 2025, Canadian standard less likely needed. ERM is noted in Hiru basis reporting. "Resource reporting and compliance: we prepare mineral resource reports in accordance with international reporting standards such as NI 43-101, JORC, and CIM. Our experts ensure t
HIRU
stealofadeal stealofadeal 3 시간 전
$ BLTHD The way this is looking with not much on the offer we are going much higher. We are sitting way under the radar. I saw 12.00 the third market maker down on the ask.
BLTHD
nowwhat2 nowwhat2 3 시간 전
scoop um up right at black swan.
XRPUSD
loophole lawyer loophole lawyer 3 시간 전
The 3 most important letters for GTCH…..P,C,T……Checkmate
GTCH
Preciouslife1 Preciouslife1 3 시간 전
https://www.mlb.com/news/mets-counting-on-trade-deadline-additions
jxyzobrien jxyzobrien 3 시간 전
hope you are well
sounds like your company is doing great
say hi when you can
flipper44 flipper44 3 시간 전
The court’s R&R did conclude and preserve NWBO illegal spoofing claims alleged to have been committed by defendants.
NWBO
x993231 x993231 3 시간 전
He does like to make a mountain out of a mole hill, but that is what he gets paid to do.  I have him and many of his alternate ID's on ignore.  He is good at asking, why, why, why.  

X. Yves is good at doing his thing.  Funny remember when Lebby said if I don't perform by the end of t
LWLG
havnagoodtime havnagoodtime 3 시간 전
So, what is the short interest and the FTD report on DPLS? Thanks in advance.
DPLS
MartinLutherKing MartinLutherKing 3 시간 전
E Pluribus Unum brothers The one and only
FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
3 June 2024
TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
RNAZ
gladeshawk gladeshawk 3 시간 전
AIRI>>>NEWS. Not a penny play but worth a look. HAWK

https://finance.yahoo.com/news/air-industries-group-closes-fiscal-120000021.html
AIRI
MartinLutherKing MartinLutherKing 3 시간 전
E Pluribus Unum brothers The one and only
FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
3 June 2024
TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
RNAZ
vein vein 3 시간 전
Hey Bubb, I see the cfo received shares , but I don't see the CEO s4??? 
CKPT